More than 22,000 American women are diagnosed with ovarian cancer each year. As Ovarian Cancer Awareness Month comes to a close, we believe in recognizing ovarian cancer organizations and advocates fighting to make a difference.
We’ve highlighted ovarian cancer organizations … Read more
To better understand ovarian cancer, as well as predict when women might relapse, it is crucial that researchers start investigating more of the molecular phases of the disease, says Peter Dottino, M.D.
Studies are already underway in this area, and … Read more
More research is needed on the other genetic mutations, besides BRCA, that patients with ovarian cancer harbor so that they can be used to help plan treatments.
However, there is hope for such research to emerge. Ophira Ginsburg, M.D., director … Read more
One of the biggest challenges for cancer survivors can be simply not thinking about their cancer once they’ve tamed the beast and been declared cancer-free. As an ovarian cancer patient, I’d venture to speculate that it’s even harder for those … Read more
By: Amy King
My mom was diagnosed with ovarian cancer on my parents’ 36th wedding anniversary. They called me together, while I was at work, to tell me the news. Our lives suddenly became very different lives.
My parents live … Read more
In 2016, the American Cancer Society projected that the number of women dying worldwide from cancer was expected to rise to 5.5 million by 2030.1 In the realm of women’s cancers, ovarian cancer is prominent and serious. A woman … Read more
By: Rebecca J. Ritzel
Education Secretary Betsy DeVos has recently drawn criticism for proposing a long list of cuts to higher education programs. Congress must mull those potentially traumatic trims while reauthorizing standard financing for students and colleges, but there’s … Read more
While precision medicine has been a modern go-to approach by physicians in various malignancies, it is demonstrating a particular benefit in ovarian cancer, especially using the method for clinical trial enrollment and in determining whether patients are eligible to receive … Read more
September is Ovarian Cancer Awareness Month and the cancer is known as the silent killer because it’s difficult to find. It usually strikes older women or those with a family history, so imagine the shock when a family from Warrington … Read more
By: Susan Gubar
As an ovarian cancer patient whose life is being extended by a clinical trial, I was delighted to learn this summer that research on gynecological cancers is undergoing an unusually productive period. But I’m dismayed that at … Read more
Women with ovarian cancer can safely stick to the standard 3-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to results of the phase III ICON8 trial to be presented at the ESMO 2017 … Read more
Administering niraparib to patients with recurrent ovarian cancer after a complete response (CR) or partial response (PR) to platinum-based chemotherapy may allow patients to continuously maintain their quality of life (QOL) during treatment, according to a study presented at the … Read more
Women with recurrent, platinum-sensitive ovarian cancer lived twice as long without disease progression when they received maintenance therapy with the PARP inhibitor rucaparib (Rubraca), a randomized trial showed.
Overall, patients treated with rucaparib had a median progression-free survival of 10.8 … Read more
Cancer patients struggle to understand what is involved in a clinical trial, even when they have participated in them. In a survey of 1090 adult cancer patients, more than half did not understand the concepts of clinical equipoise or randomization.… Read more
Using a modern DNA sequencing technique, Johns Hopkins researchers have come one step closer to diagnosing early-stage cancer patients with a simple blood draw.
The method reads free circulating DNA in a patient’s blood and detects common cancer mutations. While … Read more
By: Laura L. Holman, MD, MS
We’ve come a long way in treating ovarian cancer. This treatment has historically consisted of debulking surgery for nearly every patient, but it is evolving to become more informed and precise. Diagnostic laparoscopy, for … Read more
By: Yadira Galindo
After spending 35 years as a community college counselor, Jo-Anne Lesser retired and was looking forward to traveling with her husband, Norman. Her plans were derailed when abdominal pains had her doubled over in agony.
For seven … Read more
By: Dr. Laura Shawver, Founder of The Clearity Foundation
Ten years ago, I was recovering from chemotherapy following my ovarian cancer diagnosis. As a scientist and a cancer drug developer, I knew the odds. I also knew that progress in … Read more
Despite the existence of evidence-based guidelines supporting genetic testing for women with a history of breast and/or ovarian cancer, most of these women didn’t get tested, according to researchers.
Based on an analysis of pooled data from three cancer control … Read more
Researchers in the Perelman School of Medicine at the University of Pennsylvania have found a relationship between the genetics of tumors with germline BRCA1/2mutations—and whether the tumor retains the normal copy of the BRCA1/2 gene—and risk for primary resistance … Read more
Starting
January 1, 2025,
Clearity is joining
Ovarian Cancer
Research Alliance
(OCRA) and this website
will be redirected to
www.ocrahope.org
OCRA and Clearity are committed to serving the ovarian cancer community and providing the education, information, and support people need.
